§2077. Chronic Hazard Advisory Panels — Inbound Citations

Citations to 15 U.S.C. § 2077 as a whole

• 15 U.S.C. § 2057c(b)(2)(A)

  Go to provision →
  (A) Not earlier than 180 days after August 14, 2008, the Commission shall begin the process of appointing a Chronic Hazard Advisory Panel pursuant to the procedures of section 28 of the Consumer Product Safety Act (15 U.S.C. 2077) to study the effects on children’s health of all phthalates and phthalate alternatives as used in children’s toys and child care articles.
• 15 U.S.C. § 2080(b)(1)

  Go to provision →
  (1) The Commission may not issue—

  (A) an advance notice of proposed rulemaking for a consumer product safety rule,

  (B) a notice of proposed rulemaking for a rule under section 2076(e) of this title, or

  (C) an advance notice of proposed rulemaking for regulations under section 1261(q)(1) of this title,

  relating to a risk of cancer, birth defects, or gene mutations from a consumer product unless a Chronic Hazard Advisory Panel, established under section 2077 of this title, has, in accordance with paragraph (2), submitted a report to the Commission with respect to whether a substance contained in such product is a carcinogen, mutagen, or teratogen.
• 15 U.S.C. § 2080(b)(2)(C)

  Go to provision →
  (C) A Panel appointed under section 2077 of this title shall terminate when it has submitted its report unless the Commission extends the existence of the Panel.